Pharmena S.A. (WSE:PHR)
Poland
· Delayed Price · Currency is PLN 3.560
+0.060 (1.71%)
Jun 6, 2025, 12:20 PM CET
Pharmena Revenue
In the year 2024, Pharmena had annual revenue of 268.00K PLN, down -10.37%. Pharmena had revenue of 88.00K in the quarter ending December 31, 2024, a decrease of -31.25%.
Revenue
268.00K
Revenue Growth
-10.37%
P/S Ratio
147.95
Revenue / Employee
38.29K
Employees
7
Market Cap
39.65M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 268.00K | -31.00K | -10.37% |
| Dec 31, 2023 | 299.00K | - | - |
| Dec 31, 2022 | 299.00K | -14.91M | -98.03% |
| Dec 31, 2021 | 15.21M | 5.28M | 53.16% |
| Dec 31, 2020 | 9.93M | -1.17M | -10.51% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 12.82B |
| Synektik Spólka Akcyjna | 556.63M |
| Voxel | 556.98M |
| Celon Pharma | 215.11M |
| Ryvu Therapeutics | 97.57M |
| Centrum Medyczne ENEL-MED | 735.59M |
| Selvita | 359.79M |
| EMC Instytut Medyczny | 836.81M |